Murray B. Stein’s research while affiliated with University of California and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (742)


Distribution of standard deviation of average five-minute pulse wave intervals over full 24-hour pulse rate measurements (SDANN)
A SDANN values among All of Us participants. B Daily SDANN observations per participant.
Effect of antidepressants on the standard deviation of average five-minute pulse wave intervals over full 24-hour pulse rate measurements (SDANN)
Panel A reports SDANN association with individual antidepressant medications. Panel B reports SDANN association with antidepressant classes. SSRIs Selective Serotonin Reuptake Inhibitors, TCAs Tricyclic Antidepressants, SNRIs Serotonin and Norepinephrine Reuptake Inhibitors, SARIs Serotonin Antagonists and Reuptake Inhibitors.
Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with pulse rate variability
  • Article
  • Publisher preview available

November 2024

·

13 Reads

Molecular Psychiatry

Eleni Friligkou

·

·

·

[...]

·

This study explores the genetic and epidemiologic correlates of long-term photoplethysmography-derived pulse rate variability (PRV) measurements with anxiety disorders. Individuals with whole-genome sequencing, Fitbit, and electronic health record data (N = 920; 61,333 data points) were selected from the All of Us Research Program. Anxiety polygenic risk scores (PRS) were derived with PRS-CS after meta-analyzing anxiety genome-wide association studies from three major cohorts- UK Biobank, FinnGen, and the Million Veterans Program (NTotal =364,550). PRV was estimated as the standard deviation of average five-minute pulse wave intervals over full 24-hour pulse rate measurements (SDANN). Antidepressant exposure was defined as an active antidepressant prescription at the time of the PRV measurement in the EHR. Anxiety PRS and antidepressant use were tested for association with daily SDANN. The potential causal effect of anxiety on PRV was assessed with one-sample Mendelian randomization (MR). Anxiety PRS was independently associated with reduced SDANN (beta = −0.08; p = 0.003). Of the eight antidepressant medications and four classes tested, venlafaxine (beta = −0.12, p = 0.002) and bupropion (beta = −0.071, p = 0.01), tricyclic antidepressants (beta = −0.177, p = 0.0008), selective serotonin reuptake inhibitors (beta = −0.069; p = 0.0008) and serotonin and norepinephrine reuptake inhibitors (beta = −0.16; p = 2×10⁻⁶) were associated with decreased SDANN. One-sample MR indicated an inverse effect of anxiety on SDANN (beta = −2.22, p = 0.03). Anxiety and antidepressants are independently associated with decreased PRV, and anxiety appears to exert a causal effect on reduced PRV. Those observational findings provide insights into the impact of anxiety on PRV.

View access options

Manhattan plots depicting GWAS results
Plot a depicts the GWAS results for the full MG dataset, plot b shows the results of the early-onset MG GWAS, and plot c displays the results of the late-onset MG GWAS. The two-sided -log10P-values from the inverse-variance-weighted fixed-effects meta-analyses are plotted on the y-axis and the chromosomal position on the x-axis in ascending order from chromosome 1 through 22. The dashed red horizontal line marks the Bonferroni corrected genome-wide significance threshold (P < 5e⁻⁸). Diamonds represent the index SNPs of the discovery GWAS. Red downward triangles indicate the index SNPs with a higher P-value in the replication and discovery meta-analysis while green upward triangles represent index SNPs with a lower P-value. Asterisks (*) indicate associations not previously reported.
HLA association analysis results
The forest plot displays the top risk-conferring and protective HLA allele across all main analyses. The log10 of the odds ratio (OR) from inverse-variance-weighted fixed-effects meta-analysis is indicated as diamonds for each HLA allele and dataset used along with the 95% confidence intervals (error bars). Different P-value significance levels are indicated by asterisks for nominally significant (P < 0.05*), Bonferroni-corrected (P < 3.70e⁻⁴**), and genome-wide (P < 5e⁻⁸***). MG myasthenia gravis; EOMG early-onset myasthenia gravis, LOMG late-onset myasthenia gravis.
Performance of MG polygenic risk scores
Results of polygenic risk scoring of the combined target sample of CCM and LUMC cases and controls across all 10 PTs. Panel a shows the proportion of variance explained through the logistic regression models for PTs 1-10. Panel b shows the density distribution of the z-transformed best-performing PT (P < 0.001) for cases (orange) and controls (blue). Panel c shows the odds ratios (OR) from logistic regression models for PT P < 0.001 across ten deciles of the PRS along with the corresponding 95% confidence intervals (error bars). The target sample was scored using the combined MG leave-one-out training dataset of 5318 cases and 431,304 controls.PRS polygenic risk score.
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction

November 2024

·

54 Reads

Myasthenia gravis (MG) is a rare autoantibody-mediated disease affecting the neuromuscular junction. We performed a genome-wide association study of 5708 MG cases and 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls provided by 23andMe Inc. We identified 12 independent genome-wide significant hits (P < 5e⁻⁸) across 11 loci. Subgroup analyses revealed two of these were associated with early-onset (at age <50) and four with late-onset MG (at age ≥ 50). Imputation of human leukocyte antigen alleles revealed inverse effect sizes for late- and early-onset, suggesting a potential modulatory influence on the time of disease manifestation. We assessed the performance of polygenic risk scores for MG, which significantly predicted disease status in an independent target cohort, explaining 4.21% of the phenotypic variation (P = 5.12e⁻⁹). With this work, we aim to enhance our understanding of the genetic architecture of MG.


Clinical profile of patients with acute traumatic brain injury undergoing cranial surgery in the United States: report from the 18-centre TRACK-TBI cohort study

November 2024

·

61 Reads

The Lancet Regional Health - Americas

Background Contemporary surgical practices for traumatic brain injury (TBI) remain unclear. We describe the clinical profile of an 18-centre US TBI cohort with cranial surgery. Methods The prospective, observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (2014–2018; ClinicalTrials.gov #NCT02119182) enrolled subjects who presented to trauma centre and received head computed tomography within 24-h (h) post-TBI. We performed a secondary data analysis in subjects aged ≥17-years with hospitalisation. Clinical characteristics, surgery type/timing, hospital and six-month outcomes were reported. Findings Of 2032 subjects (age: mean = 41.4-years, range = 17–89-years; male = 71% female = 29%), 260 underwent cranial surgery, comprising 65% decompressive craniectomy, 23% craniotomy, 12% other surgery. Subjects with surgery (vs. without surgery) presented with worse neurological injury (median Glasgow Coma Scale = 6 vs. 15; midline shift ≥5 mm: 48% vs. 2%; cisternal effacement: 61% vs. 4%; p < 0.0001). Median time-to-craniectomy/craniotomy was 1.8 h (interquartile range = 1.1–5.0 h), and 67% underwent intracranial pressure monitoring. Seventy-three percent of subjects with decompressive craniectomy and 58% of subjects with craniotomy had ≥3 intracranial lesion types. Decompressive craniectomy (vs. craniotomy) was associated with intracranial injury severity (median Rotterdam Score = 4 vs. 3, p < 0.0001), intensive care length of stay (median = 13 vs. 4-days, p = 0.0002), and six-month unfavourable outcome (62% vs. 30%; p = 0.0001). Earlier time-to-craniectomy was associated with intracranial injury severity. Interpretation In a large representative cohort of patients hospitalised with TBI, surgical decision-making and time-to-surgery aligned with intracranial injury severity. Multifocal TBIs predominated in patients with cranial surgery. These findings summarise current TBI surgical practice across US trauma centres and provide the foundation for analyses in targeted subpopulations. Funding National Institute of Neurological Disorders and Stroke; US 10.13039/100000005Department of Defense; Neurosurgery Research and Education Foundation.



Targeting Operator Characteristic curve for ATE in the test sample (n = 1052). ATE, average treatment effect of exposure to high combat‐related stressors (CRS) on persistent post‐traumatic stress disorder (PTSD) defined as the difference in predicted probability of persistent PTSD in the presence versus absence of high CRS after adjusting for nonrandom exposure to high CRS with respect to the range of variables assessed in the baseline survey; Treated fraction (q), the proportion of soldiers who would either be prevented from being exposed to high CRS or protected from the effects of exposure by some to be determined intervention.
Key predictorsa (defined as those with SHAPP values of at least 5.0%) of differential resilience to the effects of high CRS on persistent post‐deployment PTSD defined by SHAP value analysis among combat arms soldiers in the STARRS PPDS sample (n = 2542)b. aKey predictors are defined as those with mean absolute SHAP values at least 5% as large as the mean absolute SHAP value of the total model. The latter is 2.1%, which means that predicted CATE for a given individual would have changed by an average of 2.1% if all significant predictors were set to the sample mean rather than to the observed values. bThe SHAP value analysis was carried out using the xgboost R package (Chen et al., 2024). The XGBoost algorithm (Chen & Guestrin, 2016) was used to predict individual differences in estimated CATE from the pre‐deployment predictors that were used in grf (Athey et al., 2024). to generate individual‐level estimates of CATE. Xgboost implements the tree SHAP method of estimating SHAP values (Lundberg & Lee, 2017). cThe SHAP value of a predictor can vary across respondents whenever there are nonlinearities and/or interactions in the model. This variation can be characterized in a bee swarm plot in which the SHAP value for each respondent is treated as a dot and values of the SHAP value are defined by the X Axis. A red dot means a higher value of the predictor. A blue dot means a lower value. If the red dots are predominantly on the right side of the swarm, it means that high scores on the predictor are associated with higher CATEs, which is equivalent to lower resilience. dAs noted above in FN a, a key predictor is defined as one with a mean absolute SHAP value at least 5% as large as the 2.1% mean absolute SHAP value of all predictors in the model. This means that any individual predictor with a mean absolute SHAP value of 0.01% (i.e., 5% of 2.1%) would be considered a key predictor. For ease of interpretation, we report proportional SHAP values (SHAPP) directly in the table. For example, a predictor with a mean absolute SHAP value of, say, 0.01% would be reported as having a SHAPP) of exactly 5.0% (i.e., 0.01/2.1). CRS, combat‐related stressors; PTSD, post‐traumatic stress disorder; SHAP, Shapley Additive Explanations; STARRS PPDS, Army Study to Assess Risk and Resilience in Servicemembers Pre‐Post Deployment Study.
A prediction model for differential resilience to the effects of combat‐related stressors in US army soldiers

October 2024

·

80 Reads

Objectives To develop a composite score for differential resilience to effects of combat‐related stressors (CRS) on persistent DSM‐IV post‐traumatic stress disorder (PTSD) among US Army combat arms soldiers using survey data collected before deployment. Methods A sample of n = 2542 US Army combat arms soldiers completed a survey shortly before deployment to Afghanistan and then again two to three and 8–9 months after redeployment. Retrospective self‐reports were obtained about CRS. Precision treatment methods were used to determine whether differential resilience to persistent PTSD in the follow‐up surveys could be developed from pre‐deployment survey data in a 60% training sample and validated in a 40% test sample. Results 40.8% of respondents experienced high CRS and 5.4% developed persistent PTSD. Significant test sample heterogeneity was found in resilience (t = 2.1, p = 0.032), with average treatment effect (ATE) of high CRS in the 20% least resilient soldiers of 17.1% (SE = 5.5%) compared to ATE = 3.8% (SE = 1.2%) in the remaining 80%. The most important predictors involved recent and lifetime pre‐deployment distress disorders. Conclusions A reliable pre‐deployment resilience score can be constructed to predict variation in the effects of high CRS on persistent PTSD among combat arms soldiers. Such a score could be used to target preventive interventions to reduce PTSD or other resilience‐related outcomes.



Associations a of non-excessive and excessive DSM-5 GAD with the onset of subsequent suicide-related outcomes Excessive v. Non-excessive
Severity of role impairment a associated with 12-month non-excessive and excessive GAD Excessive v. Non-excessive
The case for eliminating excessive worry as a requirement for generalized anxiety disorder: a cross-national investigation

October 2024

·

98 Reads

Psychological Medicine

Background Around the world, people living in objectively difficult circumstances who experience symptoms of generalized anxiety disorder (GAD) do not qualify for a diagnosis because their worry is not ‘excessive’ relative to the context. We carried out the first large-scale, cross-national study to explore the implications of removing this excessiveness requirement. Methods Data come from the World Health Organization World Mental Health Survey Initiative. A total of 133 614 adults from 12 surveys in Low- or Middle-Income Countries (LMICs) and 16 surveys in High-Income Countries (HICs) were assessed with the Composite International Diagnostic Interview. Non-excessive worriers meeting all other DSM-5 criteria for GAD were compared to respondents meeting all criteria for GAD, and to respondents without GAD, on clinically-relevant correlates. Results Removing the excessiveness requirement increases the global lifetime prevalence of GAD from 2.6% to 4.0%, with larger increases in LMICs than HICs. Non-excessive and excessive GAD cases worry about many of the same things, although non-excessive cases worry more about health/welfare of loved ones, and less about personal or non-specific concerns, than excessive cases. Non-excessive cases closely resemble excessive cases in socio-demographic characteristics, family history of GAD, and risk of temporally secondary comorbidity and suicidality. Although non-excessive cases are less severe on average, they report impairment comparable to excessive cases and often seek treatment for GAD symptoms. Conclusions Individuals with non-excessive worry who meet all other DSM-5 criteria for GAD are clinically significant cases. Eliminating the excessiveness requirement would lead to a more defensible GAD diagnosis.



Undetected suicide attempts among U.S. soldiers: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)

September 2024

·

45 Reads

Psychological Medicine

Background While previous studies have reported high rates of documented suicide attempts (SAs) in the U.S. Army, the extent to which soldiers make SAs that are not identified in the healthcare system is unknown. Understanding undetected suicidal behavior is important in broadening prevention and intervention efforts. Methods Representative survey of U.S. Regular Army enlisted soldiers ( n = 24 475). Reported SAs during service were compared with SAs documented in administrative medical records. Logistic regression analyses examined sociodemographic characteristics differentiating soldiers with an undetected SA v. documented SA. Among those with an undetected SA, chi-square tests examined characteristics associated with receiving a mental health diagnosis (MH-Dx) prior to SA. Discrete-time survival analysis estimated risk of undetected SA by time in service. Results Prevalence of undetected SA (unweighted n = 259) was 1.3%. Annual incidence was 255.6 per 100 000 soldiers, suggesting one in three SAs are undetected. In multivariable analysis, rank ⩾E5 (OR = 3.1[95%CI 1.6–5.7]) was associated with increased odds of undetected v. documented SA. Females were more likely to have a MH-Dx prior to their undetected SA (Rao-Scott χ ² 1 = 6.1, p = .01). Over one-fifth of undetected SAs resulted in at least moderate injury. Risk of undetected SA was greater during the first four years of service. Conclusions Findings suggest that substantially more soldiers make SAs than indicated by estimates based on documented attempts. A sizable minority of undetected SAs result in significant injury. Soldiers reporting an undetected SA tend to be higher ranking than those with documented SAs. Undetected SAs require additional approaches to identifying individuals at risk.


Predicting Suicides Among US Army Soldiers After Leaving Active Service

September 2024

·

52 Reads

·

1 Citation

JAMA Psychiatry

Importance The suicide rate of military servicemembers increases sharply after returning to civilian life. Identifying high-risk servicemembers before they leave service could help target preventive interventions. Objective To develop a model based on administrative data for regular US Army soldiers that can predict suicides 1 to 120 months after leaving active service. Design, Setting, and Participants In this prognostic study, a consolidated administrative database was created for all regular US Army soldiers who left service from 2010 through 2019. Machine learning models were trained to predict suicides over the next 1 to 120 months in a random 70% training sample. Validation was implemented in the remaining 30%. Data were analyzed from March 2023 through March 2024. Main outcome and measures The outcome was suicide in the National Death Index. Predictors came from administrative records available before leaving service on sociodemographics, Army career characteristics, psychopathologic risk factors, indicators of physical health, social networks and supports, and stressors. Results Of the 800 579 soldiers in the cohort (84.9% male; median [IQR] age at discharge, 26 [23-33] years), 2084 suicides had occurred as of December 31, 2019 (51.6 per 100 000 person-years). A lasso model assuming consistent slopes over time discriminated as well over all but the shortest risk horizons as more complex stacked generalization ensemble machine learning models. Test sample area under the receiver operating characteristic curve ranged from 0.87 (SE = 0.06) for suicides in the first month after leaving service to 0.72 (SE = 0.003) for suicides over 120 months. The 10% of soldiers with highest predicted risk accounted for between 30.7% (SE = 1.8) and 46.6% (SE = 6.6) of all suicides across horizons. Calibration was for the most part better for the lasso model than the super learner model (both estimated over 120-month horizons.) Net benefit of a model-informed prevention strategy was positive compared with intervene-with-all or intervene-with-none strategies over a range of plausible intervention thresholds. Sociodemographics, Army career characteristics, and psychopathologic risk factors were the most important classes of predictors. Conclusions and relevance These results demonstrated that a model based on administrative variables available at the time of leaving active Army service can predict suicides with meaningful accuracy over the subsequent decade. However, final determination of cost-effectiveness would require information beyond the scope of this report about intervention content, costs, and effects over relevant horizons in relation to the monetary value placed on preventing suicides.


Citations (43)


... While neuroticism is not officially classified as a psychiatric disorder, it is recognized as a personality trait closely associated with psychiatric conditions such as depression and anxiety. Its genetic architecture has demonstrated significant overlap with common psychiatric disorders (13). The GWAS summary data for Neuroticism were obtained from the Center for Neurogenomics and Cognitive (CNCR) (14). ...

Reference:

Shared genetic architecture of psychiatric disorders and hemorrhoidal disease: a large-scale genome-wide cross-trait analysis
A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology

Nature Human Behaviour

... An ideal approach would be to use within-family designs, as previously done for other phenotypes [46,47]. The genotype data available for DZ twins in the Swedish Twin Registry [24], together with the latest OCD PRS [48], may provide a valuable opportunity to further understand the nature of gene-environment correlations in relation to bullying and other potential risk factors. ...

Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci

... There is a powerful link between trauma and mental health; traumatic stress is a major precipitating factor in the development of several psychiatric disorders, particularly mood and anxiety disorders, such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). Yet, the molecular mechanisms linking traumatic stress to psychiatric disorder risk are only beginning to be elucidated [1][2][3] . Traumatic experiences are processed through corticolimbic circuits 4 and mount a whole body-endocrine response through glucocorticoid (GC) signaling 5,6 . ...

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

Nature Genetics

... Migraine ranks among the top ten conditions for disability-adjusted life-years, a measure of disease burden 28 , with a prevalence of > 20% in women compared to around 10% in men 2,29 . The clinical assessment of migraine is based primarily on subjective self-reports that rely on the patient's recollection of the quality and severity of frequent episodes or 'attacks' , each lasting 4-72 h and usually consisting of 4 overlapping phases (premonitory, aura, headache, and postdrome) with varying symptoms 3 . ...

Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans
  • Citing Article
  • March 2024

JAMA Network Open

... Social Anxiety Disorder (SAD) is characterized by excessive anxiety in social situations (eg, talking to others, taking part in a party) that invoke feelings of being scrutinized by others and fears of negative evaluation from others. 1 It has been estimated that SAD had a lifetime prevalence of 0.7% in China. 2 According to a recent survey among Chinese college students, over one-third reported experiencing at least one symptom of social anxiety. 3 Individuals suffering from social anxiety had a perception of decreasing quality of life, 4 with impairment in interpersonal relationships 5,6 and occupational functioning. 7 The burden of social anxiety underscores the importance of timely intervention, which issues a warrant to develop valid instruments to assess social anxiety. ...

Vulnerabilities in social anxiety: Integrating intra- and interpersonal perspectives
  • Citing Article
  • March 2024

Clinical Psychology Review

... 3 Statin medications like simvastatin 4 and lovastatin 5 were reported to attenuate neuroinflammation to reduce depression after TBI. Other drugs, such as oxyberberine, 6 buprenorphine, 7 and sertraline, 8 were reported to have protective effects on psychiatric disorders after TBI. Although post-TBI depression is often manifested, effective therapies, precise mechanisms and molecular interactions have not been identified. ...

Impact of PTSD treatment on postconcussive ymptoms in veterans: A comparison of sertraline, prolonged exposure, and their combination
  • Citing Article
  • March 2024

Journal of Psychiatric Research

... Fourth, within family analyses indicate that the effects of the PGS on some mental health phenotypes are direct (i.e., effects of inherited genetic variation on the child's phenotype) and we find no evidence for indirect genetic effects (i.e., parental genetics influencing the autistic child's mental health through the familial environment). Fifth, and finally, we find no evidence for the role of rare genetic variants on increasing the likelihood for co-occurring mental health conditions among autistic individuals, despite an association between rare variants and mental health conditions in external population cohorts 28,[64][65][66] . This pattern may reflect collider bias, limited statistical power, phenotypic heterogeneity between autistic individuals with and without rare variants 16 , or diagnostic overshadowing of mental health conditions 67,68 in autistic individuals with rare variants who may have complex support needs. ...

Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression

... These reports are already being used to guide other i nt e r ve nt i o n o u t r e a c h e f f o r t s w it h t r a n s it i o n i ng servicemembers. 41 Adding our risk scores to the reports would have value if high-risk suicide preventive interventions for transitioning soldiers like the one currently being implemented in US Army III Armored Corp 13 are found to be effective in preventing suicides. ...

Predicting Homelessness Among Transitioning U.S. Army Soldiers
  • Citing Article
  • February 2024

American Journal of Preventive Medicine

... between ADHD and nicotine dependence. Similarly, Koller et al. (2024) found several common genetic variants between ADHD and substance use disorders (SUDs), confirming genetic contribution to the comorbidity. Given the evidence of the strong relationship between SUDs and GA , common genetic factors may mediate the relationship between GA and ADHD. ...

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

Psychiatry Research

... The microbiotagut-brain axis is the idea that there is bidirectional communication between the gut microbiome, neuroendocrine and neurotransmitter systems, and immune signaling pathways (Ke et al., 2023). Additionally, alterations in this axis have been linked to several psychiatric conditions including schizophrenia, depression, and bipolar disorder (He et al., 2024). Further, dysregulation of the microbiota-gut-brain axis have been linked to physical comorbidities such as inflammatory bowel disease, cardiometabolic disorders, and diabetes (Ke et al., 2023). ...

Potential causal association between gut microbiome and posttraumatic stress disorder

Translational Psychiatry